Examiner Profile: HOWELL, THEODORE R - Patent Office Action Stats

Performance Statistics

66.7%

Allow Rate

+6.7% vs TC avg

1,073

Total Applications

+25.5%

Interview Lift

943

Avg Prosecution Days

Based on 1016 resolved cases, 2023–2026

2.6%

§101 Eligibility

18.6%

§102 Novelty

37.1%

§103 Obviousness

15.6%

§112 Clarity

App #	Title	Status	Assignee
18156749	SEMIFLUORINATED ALKANE COMPOSITIONS	Non-Final OA	Novaliq GmbH
17832911	Immunomodulation by IAP Inhibitors	Non-Final OA	DANA-FARBER CANCER INSTITUTE, INC.
18745626	METHOD OF TREATING PAIN OR INTERSTITIAL CYSTITIS USING INDOLE COMPOUND	Non-Final OA	Japan Tobacco Inc.
18613350	COVALENT AND NON-COVALENT INHIBITORS OF CORONAVIRUS PAPAIN-LIKE PROTEASE	Non-Final OA	Northeastern University
18671814	TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY	Non-Final OA	Scientific Holdings, LLC
18530143	TERPENE-BASED COMPOSITIONS, METHODOLGIES FOR CREATION AND PRODUCTS THEREBY	Non-Final OA	Scientific Holdings, LLC
18530198	TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY	Non-Final OA	Scientific Holdings, LLC

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.